Related references
Note: Only part of the references are listed.Predicting Benefit From Evolocumab Therapy in Patients With Atherosclerotic Disease Using a Genetic Risk Score Results From the FOURIER Trial
Nicholas A. Marston et al.
CIRCULATION (2020)
Genome-wide association analysis of venous thromboembolism identifies new risk loci and genetic overlap with arterial vascular disease
Derek Klarin et al.
NATURE GENETICS (2019)
Is the lower risk of venous thromboembolism with statins related to low-density-lipoprotein reduction? A network meta-analysis and meta-regression of randomised controlled trials
Francesco Zaccardi et al.
ATHEROSCLEROSIS (2018)
Alirocumab and Cardiovascular Outcomes after Acute Coronary Syndrome
G. G. Schwartz et al.
NEW ENGLAND JOURNAL OF MEDICINE (2018)
Statins and secondary prevention of venous thromboembolism: pooled analysis of published observational cohort studies
Setor K. Kunutsor et al.
EUROPEAN HEART JOURNAL (2017)
Lipid levels and risk of venous thrombosis: results from the MEGA-study
Vania M. Morelli et al.
EUROPEAN JOURNAL OF EPIDEMIOLOGY (2017)
Evolocumab and Clinical Outcomes in Patients with Cardiovascular Disease
Marc S. Sabatine et al.
NEW ENGLAND JOURNAL OF MEDICINE (2017)
Lipoprotein(a) as a Risk Factor for Venous Thromboembolism: A Systematic Review and Meta-analysis of the Literature
Francesco Dentali et al.
SEMINARS IN THROMBOSIS AND HEMOSTASIS (2017)
Proprotein convertase subtilisin/kexin type 9 (PCSK9) Deficiency is Protective Against Venous Thrombosis in Mice
Hui Wang et al.
SCIENTIFIC REPORTS (2017)
Statins and primary prevention of venous thromboembolism: a systematic review and meta-analysis
Setor K. Kunutsor et al.
LANCET HAEMATOLOGY (2017)
Venous thromboembolism has the same risk factors as atherosclerosis A PRISMA-compliant systemic review and meta-analysis
Yuhong Mi et al.
MEDICINE (2016)
Next-generation genotype imputation service and methods
Sayantan Das et al.
NATURE GENETICS (2016)
A global reference for human genetic variation
David M. Altshuler et al.
NATURE (2015)
Second-generation PLINK: rising to the challenge of larger and richer datasets
Christopher C. Chang et al.
GIGASCIENCE (2015)
Genetic Evidence That Lipoprotein(a) Associates With Atherosclerotic Stenosis Rather Than Venous Thrombosis
Pia R. Kamstrup et al.
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY (2012)
Lipid parameters, lipid lowering drugs and the risk of venous thromboembolism
Aurelien Delluc et al.
ATHEROSCLEROSIS (2012)
Apolipoprotein(a) Genetic Sequence Variants Associated With Systemic Atherosclerosis and Coronary Atherosclerotic Burden But Not With Venous Thromboembolism
Anna Helgadottir et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2012)
Everyone under statin?
Helene Vaillant-Roussel et al.
EXERCER-LA REVUE FRANCOPHONE DE MEDECINE GENERALE (2012)
Lipid levels do not influence the risk of venous thromboembolism Results of a population-based cohort study
Inge M. van Schouwenburg et al.
THROMBOSIS AND HAEMOSTASIS (2012)
Effect of Statins on Venous Thromboembolic Events: A Meta-analysis of Published and Unpublished Evidence from Randomised Controlled Trials
Kazem Rahimi et al.
PLOS MEDICINE (2012)
The effects of lowering LDL cholesterol with statin therapy in people at low risk of vascular disease: meta-analysis of individual data from 27 randomised trials
B. Mihaylova et al.
LANCET (2012)
Risk Factors for Venous Thromboembolism Results From the Copenhagen City Heart Study
Anders G. Holst et al.
CIRCULATION (2010)
Fast model-based estimation of ancestry in unrelated individuals
David H. Alexander et al.
GENOME RESEARCH (2009)
Lipid biomarkers, hormone therapy and the risk of venous thromboembolism in women
B. M. Everett et al.
JOURNAL OF THROMBOSIS AND HAEMOSTASIS (2009)
A Randomized Trial of Rosuvastatin in the Prevention of Venous Thromboembolism
Robert J. Glynn et al.
NEW ENGLAND JOURNAL OF MEDICINE (2009)
Rosuvastatin to Prevent Vascular Events in Men and Women with Elevated C-Reactive Protein
Paul M. Ridker et al.
NEW ENGLAND JOURNAL OF MEDICINE (2008)
Lipoprotein (a) and venous thromboembolism in adults: A meta-analysis
Francesco Sofi et al.
AMERICAN JOURNAL OF MEDICINE (2007)
Increased plasma levels of lipoprotein(a) and the risk of idiopathic and recurrent venous thromboembolism
R Marcucci et al.
AMERICAN JOURNAL OF MEDICINE (2003)
Cardiovascular risk factors and venous thromboembolism incidence - The longitudinal investigation of thromboembolism etiology
AW Tsai et al.
ARCHIVES OF INTERNAL MEDICINE (2002)
Share Paper
